The National Women’s Law Center (NWLC) in a statement labeled the decision as “reinstating outdated, medically unnecessary restrictions” on the drug’s use. The NWLC called mifepristone “one of the most accessible, safe, and effective forms” of abortion care.

Goss Graves, CEO and president of the NWLC, said the decision will make it “impossible to access…the only way for [patients] to obtain health care.”